Novo Nordisk A/S (NVO)
NYSE·Healthcare·Drug Manufacturers - General
$38.66
-1.21%
Mkt Cap $176.82B
Analyst Ratings
No recent rating data.
Price Target (18 analysts)
$47.00
Range $47.00 – $47.00
Implied Upside
+21.6%
Consensus $47.00 vs current $38.66